New Personalized mRNA Vaccine Might Be Effective in Fighting Pancreatic Cancer
![T cells of 50 per cent of the participants were able to identify the cancer neoantigens in their blood.](https://healthwire.co/wp-content/uploads/2023/05/cancer-1.jpg)
The new mRNA vaccine for pancreatic cancer has been developed by German drug maker BioNTech that developed one of the first COVID-19 shots with Pfizer.
Share
Search Results for
Input your search keywords and press Enter.